New Vice President of Research at Hamilton Health Sciences

  • November 26, 2014
  • News

A message from Rob MacIsaac, President and CEO

Dr. Salim Yusuf, Vice President of Research at Hamilton Health Sciences (HHS), Founder and Executive Director of the Population Health Research Institute (PHRI), and Professor of Medicine at McMaster University will begin a two-year term as President of the World Heart Federation in January 2015.

As one of the most highly regarded and cited scientists in the world, Dr. Yusuf’s thought leadership is in high demand. His work has had an enormous impact on patient care around the globe and has put Hamilton on the map as a destination of choice for other leading researchers and aspiring researchers. We know that he will have an equally profound impact on the awareness, advocacy, research and capacity building efforts of the federation.

In consideration of this prominent appointment, Dr. Yusuf will be stepping away from his administrative duties as Vice President of Research at HHS so that he can provide the necessary visionary leadership to advance the work of the Federation. He has agreed to continue on in his role as an important thought leader for research across HHS in the capacity of Chief Scientist in which role he intends to continue with and expand on the incredible success he has achieved to date. He will also continue on as Director of PHRI at HHS.

I am pleased to announce that Frank Naus, currently the Director of Research Administration, has been appointed Vice President of Research. I am confident that Frank will continue the tradition of responsible stewardship of the research enterprise at HHS in his new role as Vice President.

Within the research portfolio at HHS, Frank will focus on enhancing the success of and supporting the activities of the Population Health Research Institute; the Escarpment Cancer Research Institute; the Thrombosis and Atherosclerosis Research Institute; the Offord Centre for Child Studies; the Geriatric Education and Research in Aging Sciences Centre; the Clinical Research Clinical Trials Laboratory; and all of the research groups and researchers at HHS.

Frank’s career has spanned over 25 years and he has amassed substantial expertise in pharmaceutical, clinical and hospital research with organizations such as PharmaNet LLP in London and Astra Pharma Inc. in Mississauga. His board and committee service has included Clinical Trials Ontario REB Streamlining Working Group, and the Canadian Medical Hall of Fame.

Frank is currently a Doctorate in Business Administration candidate at Walden University, and holds a Master of Business Administration from Wilfrid Laurier University, a Master of Science and Bachelor of Science from the University of Waterloo.